Financial Survey: Zovio (OTCMKTS:ZVOI) and Nexalin Technology (NASDAQ:NXL)

Zovio (OTCMKTS:ZVOI) and Nexalin Technology (NASDAQ:NXL) are both business services companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, risk, profitability, valuation, analyst recommendations and earnings.

Profitability

This table compares Zovio and Nexalin Technology’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Zovio	N/A	N/A	N/A
Nexalin Technology	-3,018.12%	-191.88%	-166.43%

Volatility and Risk

Zovio has a beta of 20.28, meaning that its stock price is 1,928% more volatile than the S&P 500. Comparatively, Nexalin Technology has a beta of 3.56, meaning that its stock price is 256% more volatile than the S&P 500.

Earnings and Valuation

This table compares Zovio and Nexalin Technology”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zovio	N/A	N/A	N/A	N/A	N/A
Nexalin Technology	$300,000.00	23.50	-$8.22 million	($0.47)	-0.73

Zovio has higher earnings, but lower revenue than Nexalin Technology.

Analyst Ratings

This is a breakdown of current recommendations for Zovio and Nexalin Technology, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zovio	0	0	0	0	0.00
Nexalin Technology	1	0	0	0	1.00

Institutional & Insider Ownership

0.1% of Zovio shares are owned by institutional investors. Comparatively, 0.7% of Nexalin Technology shares are owned by institutional investors. 2.3% of Zovio shares are owned by insiders. Comparatively, 25.3% of Nexalin Technology shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

About Zovio

Zovio, Inc. operates as an education technology services company that partners with higher education institutions and employers to deliver solutions and learning experiences. It provides student recruitment and enrollment systems, retention strategies, educational tools, and curriculums. The company was founded by Wayne Clugston and Andrew S. Clark in May 1999 and is headquartered in Chandler, AZ.

About Nexalin Technology

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.